Basimglurant (NOE-101)

basimglurant · Noema Pharma AG

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Basimglurant (NOE-101), covering 2025-06-04 to 2026-01-23. Get the full timeline:

Most recent: Clinical Trial Update: An Efficacy and Safety Study of Basimglurant (NOE-101) in Patients With Trigeminal Neuralgia. [Phase 2, Phase 3]